Bad Blood is a great book.  It's a fast read, it's interesting and you should read it.  I want to only discuss one aspect of investing with regards to my takeaways from this book.

In November of 2006, Theranos raised money at a valuation of $165m.  Approximately 8 years later, in February of 2014, Theranos raised additional capital at a valuation of $9 Billion.  Was the investor that chose not...

 

Please join here to view this post.  Why Join BHI Members?